Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Expert Opinion on Investigational Drugs
|
June 6, 2022
Current emerging and investigational drugs for the treatment of chronic hand eczema
Julia Cheng, Paola Facheris, Benjamin Ungar, et al.
Cellular & Molecular Immunology
|
March 17, 2023
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
Paola Facheris, Jane Jeffery, Ester Del Duca, et al.
Frontiers in Immunology
|
April 27, 2026
Effects of tildrakizumab on circulating T cells in autoreactive psoriatic patients
Paola Facheris, Rebecca Favaro, Mario Valenti, et al.
Dermatology and Therapy
|
April 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study
Paola Facheris, Francesco Piscazzi, Giovanni Fiorillo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 13, 2023
Targeting type 2 immune activation beyond atopic dermatitis
Donald Y M Leung, Paola Facheris, Karen A Veverka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2025
Reply to Hagino et al.: 'Importance of Upadacitinib dose escalation prior to switch to lebrikizumab'
Luigi Gargiulo, Matteo Bianco, Luciano Ibba, et al.
The Journal of Dermatological Treatment
|
August 9, 2023
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients
Francesco Piscazzi, Luigi Gargiulo, Luciano Ibba, et al.
Dermatology Reports
|
July 3, 2024
Atypical facial pustular folliculitis by <i>Klebsiella pneumoniae</i>: a case report
Mario Valenti, Andrea Cortese, Paola Facheris, et al.
Dermatology and Therapy
|
April 9, 2026
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings
Francesco D'Oria, Francesco Piscazzi, Paola Facheris, et al.
The Journal of Dermatological Treatment
|
May 29, 2023
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Expert Opinion on Investigational Drugs
|
June 6, 2022
Current emerging and investigational drugs for the treatment of chronic hand eczema
Julia Cheng, Paola Facheris, Benjamin Ungar, et al.
Cellular & Molecular Immunology
|
March 17, 2023
The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
Paola Facheris, Jane Jeffery, Ester Del Duca, et al.
Frontiers in Immunology
|
April 27, 2026
Effects of tildrakizumab on circulating T cells in autoreactive psoriatic patients
Paola Facheris, Rebecca Favaro, Mario Valenti, et al.
Dermatology and Therapy
|
April 24, 2026
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study
Paola Facheris, Francesco Piscazzi, Giovanni Fiorillo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 13, 2023
Targeting type 2 immune activation beyond atopic dermatitis
Donald Y M Leung, Paola Facheris, Karen A Veverka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2025
Reply to Hagino et al.: 'Importance of Upadacitinib dose escalation prior to switch to lebrikizumab'
Luigi Gargiulo, Matteo Bianco, Luciano Ibba, et al.
The Journal of Dermatological Treatment
|
August 9, 2023
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients
Francesco Piscazzi, Luigi Gargiulo, Luciano Ibba, et al.
Dermatology Reports
|
July 3, 2024
Atypical facial pustular folliculitis by <i>Klebsiella pneumoniae</i>: a case report
Mario Valenti, Andrea Cortese, Paola Facheris, et al.
Dermatology and Therapy
|
April 9, 2026
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings
Francesco D'Oria, Francesco Piscazzi, Paola Facheris, et al.
The Journal of Dermatological Treatment
|
May 29, 2023
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, et al.
Page
of 6